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Introduction
The re-appearance of  tuberculosis (TB) in the era of  
global human immunodeficiency virus (HIV) epidemic is 
a threat to public health in high burden countries. These 
two diseases are causes of  high mortality among infectious 
diseases [1]. In people living with HIV, tuberculosis is the 
leading cause of  mortality. Globally, out of  the 35.3 million 
people living with HIV, 12 million (33%) are infected with 
tuberculosis [2]. 
In 2011, it was estimated that 8.7 million new cases of  TB 
and 2.5 million new cases of  HIV were recorded [1, 3]. Of  
these new TB infections, 1.1 million (13%) were among 
people living with HIV [3].  Most of  the burden of  the 
dual HIV/TB co-infection is in Africa in which one-third 
of  the approximated 2.3 million people who developed 
TB were HIV positive [1]. Of  those with HIV/TB co-
infection, 75% live in sub-Saharan Africa. Other regions 
Abstract
Objective
To determine the prevalence of  HIV/TB co-infection among patients attending the HIV clinic at Juba Teaching 
Hospital (JTH) from 2011 to 2013. 
Method and Materials
This was a retrospective study using data abstracted from the registration book in the HIV clinic. A data sheet was used 
to collect relevant variables. Data were entered, organized and analyzed using SPSS Version 20 Software. A p-value of  
0.05 or less was considered significant.
Results
Out of  2,577 patients attending the HIV clinic in JTH from 2011 to 2013, 2,547 (99%) were included in this study. Of  
these, 27.4% were seen in 2011, 34.1% in 2012 and 38.5% in 2013. There were 1,010 (39.7%) males and 1,537(60.3%) 
females with a male to female ratio of  2:3. The mean age (x, SD, range) was 30.8 +/-10.8 (0.2-68) years which for 
males was 33.3+/- 12.2 (1-68) years and 29.1+/-9.5 (0.2-65) years for females. There were 2,318 (91%) HIV mono-
infected patients and 229 (9%) HIV/TB co-infected patients. There were 122 HIV/TB co-infected males and 107 
females. 39.3% of  patients with HIV/TB were aged 25-34 years, and 9.3% were aged 0-14 years. The p-value between 
the groups and within the groups was statistically significant at p= 0.005. Munuki payam had the highest percentage 
(31.7%) of  HIV/TB co-infection.
Conclusion
HIV/TB remains a major challenging health problem with a prevalence of  9%.
like India and Eastern Europe are also affected [4, 5].
The HIV epidemic is the main factor in the re-emergence 
of  TB epidemic worldwide. One in eight new cases 
of  TB occur in HIV positive individuals. The risk of  
developing active TB in HIV patients increases from 5 to 
15% yearly depending on the level of  the immune status 
[6, 7]. The risk of  TB doubles within one year of  HIV 
infection [8]. Hence people who are infected with HIV 
have increased susceptibility to active TB. This is because 
HIV modifies the pathogenesis of  TB by increasing the 
risk of  developing active TB in those with latent infection 
as well as in those newly exposed to TB. Up to 10% of  
people latently infected with TB will develop active TB 
in a population of  HIV-uninfected people. But in an 
HIV positive population, there is 20 to 30 fold increase 
in relative risk of  developing TB disease from latent 
infection relative to an HIV negative population [9].
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Several putative factors play an important role in the 
epidemiology of  HIV infection in South Sudan: 
With the signing of  a peace agreement in 2005, there • 
has been a lot of  rural-urban movement and travel 
between South Sudan and neighbouring countries 
with high HIV and TB rates.  
A high commercial sex workers presence in the towns • 
[10].
Through a collaboration between the National Ministry of  
Health and the United Nation Development Programme 
(UNDP), a TB/HIV collaborative programme was 
developed for South Sudan. The objectives are to:
Establish a mechanism for collaboration between TB 1. 
and HIV/AIDS programmes;
Decrease the burden of  TB in people living with HIV 2. 
and AIDS;
Decrease the burden of  HIV in TB patients; and 3. 
Obtain political commitment to collaborative TB/4. 
HIV activities and create partnerships for development 
and collaboration [11]. 
Because of  this collaboration, 29 coordinating bodies were 
formed for TB/HIV activities at all levels of  the country. 
Likewise there are 140 TB/HIV service delivery points 
and 124 facilities that provide HIV voluntary counseling 
and testing and TB screening [11].
There is a paucity of  published data on HIV/TB co-
infection in South Sudan. The UNDP-SS has estimated 
the co-infection rate to be between 10-20%. An estimate 
in 2010 was 9.7% for TB/HIV co-infection patients and 
11.4% for all forms of  TB [11]. We therefore undertook 
this study with the aim of  establishing the prevalence 
of  HIV/TB co-infection among HIV positive patients 
attending the HIV clinic at the Juba Teaching Hospital 
(JTH).
Materials and method
This was a retrospective study that involved the collection 
of  variables from records at the HIV clinic at the Juba 
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45-54 25 (11%) 19 (4%) 44
41 
(10.7%)
36 (7%) 77 46 (11.7%) 33 (5.6%) 79
55-64 10 (4%) 4 (0.8%) 14 11 (2.9%) 6 (1%) 17 10 (2.5%) 3 (0.5%) 13
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Table 2. Distribution of all patients according to their HIV or 








n % n %
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Male 1,010 888 88 122 12
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Teaching Hospital.
We collected demographic 
data (age, sex and residential 
area), and the HIV and 
HIV/TB status of  the 
patients who attended from 
January 2011 to December 
2013. Included were all cases 
who had all these variables. 
A case was excluded if  
one of  the variables was 
absent. Therefore out of  
2,577 patients’ records 
examined, only 2,547 were 
considered. 
The information was 
collected into data sheets, 
verified and entered into 
SPSS Version 20 (IBM). Results were displayed in form 
of  descriptive statistics and the Chi-square test was used 
to compare categorical data. A p-values of  p<0.05 were 
considered to be statistically significant. 
Ethical approval was obtained from the ethical committee 
in the National Ministry of  Health.
Results
Out of  2,577 patients attending the HIV clinic in JTH 
from 2011 to 2013, 2,547 (99%) were included in this 
study. Of  these, 27.4% were seen in 2011, 34.1% in 2012 
and 38.5% in 2013. There were 1,010 (39.7%) males and 
1,537 (60.3%) females with a male to female ratio of  2:3. 
The mean age (x, SD, range) was 30.8 +/-10.8 (0.2-68) 
years in which for males was 33.3+/- 12.2 (1-68) years and 
29.1+/-9.5 (0.2-65) years for females.
Table 1 shows the distribution of  sex and age among 
patients attending the HIV clinic in 2011, 2012 and 2013.
Of  the 2,547 patients 2,318 (91%) were HIV mono-
infected and 229 (9%) were HIV/TB co-infected. Of  the 
229 HIV/TB co-infected patients, 122 were males and 
107 were females. Table 2 and 3 show the distribution 
(number and %) of  patients attending the HIV clinic at 
JTH according to their HIV or HIV/TB status, sex, and 
age group.
Figure 1 shows that:
The majority (39%) of  patients with HIV/TB belongs • 
to the age group 25-34 years. 
9% were in the age group of  0-14 years.• 
Table 4 shows that Muniki payam had the highest 
percentage (31.7%) of  patients with HIV/TB co-
infection.
Discussion
Human immunodeficiency virus and tuberculosis are a 
major challenge in public health in many countries, where 
these conditions are endemic. In this study the prevalence 
of  TB/HIV co-infection among patients who are HIV 
positive is 9%. This was similar to the UNDP-SS estimate 
of  2010 [11]. Studies in Nigeria showed a prevalence 
of  7.8% and in Tanzania a prevalence of  8.5% [12, 13] 
but lower than prevalences found in studies conducted 
in Northern Tanzania  30% [13], Cambodia 19.3% [14] 
and India 18.9% [15]. This variation may be due to 
the geographical and socio-economical status of  the 
countries. It has been noted that tuberculosis is seen more 
in countries that are poor [16]. Our findings may not be 
representative of  the whole of  South Sudan because the 
data were collected from only one centre.  
Among the 229 patients with HIV and TB co-infection, 
the proportion of  co-infection according to sex was 12% 
(122/1010) for males and 7.5% (107/1430) for females. 
Studies conducted in Nigeria by Olaniran et al 2011 [17] 
and globally by Abeld et al 2002 [18] found similar results. 
Males have the tendency of  migrating from one place to 
another searching for better work. As a result of  this, they 
are in contact with more people increasing the chances of  
exposure to mycobacterium bacilli. It is worth mentioning 
that reactivation of  TB is seen most commonly in patients 
with HIV/AIDS.
A statistically significant majority of  the patients affected 
with HIV/TB co-infections belonged to the 25-34 year 
age group. However, the proportion of  all 25-34 year old 
HIV-positive patients with the co-infection was 8% - the 
lowest of  all the age groups. This result is in line with 
studies by Olaniran et al 2011 [17]. This age group usually 
has responsibilities which involve strenuous activities to 
meet socio-economical needs of  their families. As such 













0-14yrs 68 (7.7%) 62 (4.3%) 130 (5.6%) 9 (7.4%) 12 (11.2%) 21(9.2%) 
15-24yrs 53 (6%) 316 (22.1%) 369(15.9%) 8 (6.6%) 19 (17.8%) 27(11.8%)
25-34yrs 361 (40.7%) 685 (47.9%) 1046(45.1%) 48 (39.3%) 42 (39.3%) 90(39.3%)
35-44yrs 279 (31.4%) 275 (19.2%) 554(23.9%) 31 (25.4%) 22 (20.6%) 53(23.1%)
45-54yrs 95 (10.7%) 78 (5.5%) 173(7.5%) 17 (13.9%) 10 (9.3%) 27(11.8%)
55-64yrs 26 (2.9%) 11 (0.8%) 37(1.6%) 5 (4.1%) 2 (1.9%) 7(3.1%)
65-74yrs 6 (0.7%) 3 (0.2%) 9(0.4%) 4 (3.3%) 0 (0%) 4(1.7%)
Total 888 1430 2318 122 107 229
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they are more prone to associate with infected patients 
in one way or another. But in our study it seems they 
are less active and therefore they have less contact. This 
group reflects the reproductive and economic power of  
the nation. This may reflect prevalence of  HIV/TB in the 
community since this is a sexually active group.
In our study children accounted for 9.2% of  the 229 HIV/
TB co-infected cases. Worldwide children contribute to 
10% of  HIV/TB infections although the prevalence varies 
from country to country. In South Africa the incidence of  
TB among children infected with HIV is 23% [19] and in 
London it is 5.5% [20]. In our study it is closely similar 
the global average and better than South Africa. This may 
be due to the fact that our study is based in one centre. 
Hence the results do not reflect prevalence of  the whole 
country. It has been shown that with increase in coverage 
with anti-retroviral drugs, the incidence of  TB decreases 
[21].
In our study a high proportion of  HIV/TB cases were 
from Munuki payam (31.7%).This is because this payam 
is part of  Juba City Council which has the largest (61%) 
number of  inhabitants in comparison to all payams of  
Juba county.  Furthermore urban life is associated with 
factors such as multiple sexual partners, sex workers, poor 
sanitation, overcrowding, and poor socioeconomic status, 
which can increase the likelihood of  HIV/TB infection. 
There is an increasing trend of  HIV/TB co-infection 
over time in this study. Cases increased from 27.4% of  
all patients seen in the HIV clinic in 2011 to 38.5% in 
2013. This is an increment of  11.1%. This may be due 
to socioeconomically instability as well as inter and intra 
tribal conflicts in the others parts of  the country. So people 
tend to move to the capital for a better and safer life. Or 
it may be due to the fact that there is now a good public 
awareness programme that encourages the population to 
come forward for voluntary HIV testing. 
In conclusion, HIV/TB still remains a major challenging 
health problem in this youngest nation with a prevalence 
of  9%. Males are more co-infected than females with the 
greatest number of  co-infected patients being in the age 
group of  25-34 years.
Recommendations
Studies to document trends in HIV/TB co-infection 1. 
should be implemented across the country.
All TB cases need to be screened for HIV so that 2. 
HIV/TB is detected early and managed promptly. 
Public awareness, community mobilization through 3. 
different interventions should be encouraged and 
stepped up especially in areas where there is high 
prevalence of  HIV and TB. This will help in the 
control and prevention of  the dual co-infection which 
is challenging the health system.
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Figure 1. Distribution of HIV/TB co-infection of patients attending HIV 
clinic in JTH according to age group
Table 4. Distribution of HIV/TB co-infected patients 
attending the HIV clinic in JTH according to 
residence (states, counties and payams)
n %
Juba City Council Juba town 261 10
Kator 610 23.9
Munuki 807 31.7
Other payams in 
Juba county
530 20.8
Elsewhere in Central 
Equatoria (CES)
285 11.2
Other States 62 2.4
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Congratulations to three members of  the SSMJ editorial board
Professor John Adwok Adieng who has just been appointed Chairperson of  the new 18-person South Sudan General Medical 
Council, and  Dr Edward Luka who is appointed a member of  the same Council. 
Professor Adwok says, “It will not be an easy task to build this hitherto neglected pillar of  our healthcare system. The establishment 
of  a guiding regulatory body is the foundation of  any system. It provides the base on which efficient and effective processes could 
be run by a dedicated and motivated team to ensure successful outcomes.”
Dr Eluzai Hakim who has been nominated as Clinical Educator of  the Year for 2014 at St Mary’s Hospital, Isle of  Wight, UK, 
and whose name will be displayed on the hospital honours board. 
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